Abstract
To review the direct and indirect effects on the central nervous system (CNS) of systemically administered immuno-modulatory therapies in use or under evaluation for the relapsing forms of multiple sclerosis (MS).
Original language | English |
---|---|
Pages (from-to) | 951-7 |
Number of pages | 7 |
Journal | Clinical Neurology and Neurosurgery |
Volume | 110 |
Issue number | 9 |
DOIs | |
Publication status | Published - Nov 2008 |
Keywords / Materials (for Non-textual outputs)
- Animals
- Multiple Sclerosis
- Recombinant Proteins
- Antineoplastic Agents
- Humans
- Interferon Type I
- Peptides
- Propylene Glycols
- Sphingosine
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Central Nervous System
- Immunosuppressive Agents